| __timestamp | BioMarin Pharmaceutical Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 2613100000 |
| Thursday, January 1, 2015 | 152008000 | 2891500000 |
| Friday, January 1, 2016 | 209620000 | 3228800000 |
| Sunday, January 1, 2017 | 241786000 | 2966700000 |
| Monday, January 1, 2018 | 315264000 | 2900200000 |
| Tuesday, January 1, 2019 | 359466000 | 3064100000 |
| Wednesday, January 1, 2020 | 524272000 | 3248100000 |
| Friday, January 1, 2021 | 470515000 | 2722500000 |
| Saturday, January 1, 2022 | 483669000 | 2996200000 |
| Sunday, January 1, 2023 | 577065000 | 2975200000 |
| Monday, January 1, 2024 | 580235000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. BioMarin Pharmaceutical Inc. and Perrigo Company plc, two giants in the industry, have shown contrasting trends in their cost of revenue from 2014 to 2023. BioMarin's cost of revenue has surged by approximately 345%, reflecting its aggressive growth strategy and increased production costs. In contrast, Perrigo's cost of revenue has remained relatively stable, with only a 14% increase over the same period, indicating a more controlled cost management approach.
Analyzing Cost of Revenue: Sanofi and BioMarin Pharmaceutical Inc.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.
Analyzing Cost of Revenue: Grifols, S.A. and Perrigo Company plc
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
Analyzing Cost of Revenue: Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.